West Launches New Prefillable Syringe System that Streamlines Biologic Delivery

The global commercial availability of the West Pharmaceutical Services' Synchrony S1 prefillable syringe (PFS) system, planned to coincide with the Pharmapack 2026 conference in Paris, Jan 21-22, marks a significant development for specialists in drug delivery and containment. The introduction of this system reflects a strategic alignment with current shifts in the global drug pipeline, particularly regarding the increasing complexity of combination products.

Why is a shift in patient care driving new containment requirements?

The transition of medical treatment from clinical settings to the home environment has created new challenges for drug developers and manufacturers. Stacey Vaughan, VP, Marketing and Portfolio Management at West, commented in a press release, “as a market leader, West closely monitors shifts in the global drug pipeline by emerging companies, particularly the growing demand for combination products alongside the movement of care from hospital to home, both of which introduce new complexity into regulatory and development processes.” She added that “this surge of innovation across the industry further highlights why now is the right time to introduce West Synchrony S1 prefillable syringe system” (1).

The Synchrony S1 PFS system includes a broad product portfolio designed for specific therapeutic needs. For biologics, the system offers 1 ml long and 2.25 ml staked needle options (1). Vaccine developers can utilize 1 ml standard staked needle and Luer lock options. The inclusion of both rigid and soft needle shields for staked needle systems, integrated tip caps for Luer lock systems, and the use of high-performance NovaPure and FluroTec barrier film plungers supports manufacturing and assembly flexibility.

How can integrated delivery systems streamline the path through clinical trials?

The primary benefit of these integrated systems is the potential to simplify the supply chain and regulatory hurdles associated with clinical development, according to West (1).. Educational sessions at the Pharmapack event will emphasize the importance of moving away from piecemeal component sourcing toward integrated, verified prefillable syringe systems from a single source (1). This approach is most relevant when steering combination products through clinical trials.

A supplier’s ability to support these developments is often linked to their manufacturing scale and global presence. With 25 manufacturing facilities worldwide and an annual delivery of more than 41 billion components and devices, the provider’s infrastructure is designed to support both established and emerging drug developers in ensuring safe and effective delivery (1).

What other innovations are being shown at Pharmapack 2026?

A significant development in solid oral dosage packaging is the use of polypropylene (PP)-based mono-materials, such as the PharmaGuard line from SÜDPACK Medica, which the company plans to highlight at Pharmapack (2). These materials allow manufacturers to address toxicological and environmental concerns while maintaining critical performance metrics, including a water vapor barrier and "outstanding push-through performance". These solutions are designed for processability on standard packaging machinery. They reduce the need for line re-tooling, allowing scientists to reduce a product's carbon footprint without sacrificing stability or regulatory compliance.

How can streamlined procurement improve supply chain agility?

Beyond primary packaging, the industry requires agility in the procurement of components for sterile medical devices and diagnostic products. The introduction of services like MedHub reflects a focus on the industry's need for "minimal effort and reliable delivery" of pre-made bags and pouches (2). These solutions support the assembly of surgical kits and the protection of glass vials or syringes, ensuring they remain sterile prior to filling. By utilizing standardized clean room manufacturing and verified high-barrier films, clinicians can better manage the sterility and stability of the entire process chain.

References:

1. West Pharmaceutical Services. West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack. Press Release. Jan 19, 2026
2. SÜDPACK Medica. A Strong Partner to the Healthcare Industry: SÜDPACK Medica at PharmaPack 2026 in Paris. Press Release. Jan. 15, 2026.